Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03559049 |
Title | Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | University of Michigan Cancer Center |
Indications | |
Therapies |
Carboplatin + Pembrolizumab + Pemetrexed Disodium + Rucaparib |
Age Groups: | senior | adult |
Covered Countries | USA |